Pt. Tanabe Indonesia Sustainability Profile
Pt. Tanabe Indonesia, a prominent player in the pharmaceutical industry, is headquartered in Indonesia and operates extensively across Southeast Asia. Founded in 1970, the company has established itself as a leader in the production of high-quality pharmaceutical products, including prescription medications and over-the-counter solutions. With a commitment to innovation and excellence, Pt. Tanabe Indonesia has achieved significant milestones, including the introduction of several unique formulations that cater to local health needs. The company is renowned for its rigorous quality control processes and adherence to international standards, ensuring the safety and efficacy of its offerings. As a subsidiary of Tanabe Seiyaku Co., Ltd., Pt. Tanabe Indonesia has solidified its market position through strategic partnerships and a robust distribution network, making it a trusted name in healthcare across the region.
DitchCarbon Score
How does Pt. Tanabe Indonesia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pt. Tanabe Indonesia's score of 17 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pt. Tanabe Indonesia's reported carbon emissions
In 2016, Pt. Tanabe Indonesia reported total carbon emissions of approximately 98,000,000 kg CO2e. This figure includes 35,447,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 71,805,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. Additionally, the company reported Scope 3 emissions of about 40,959,000 kg CO2e, specifically from capital goods. Comparatively, emissions in previous years were higher, with 108,000,000 kg CO2e in 2015 and 117,000,000 kg CO2e in 2014, indicating a downward trend in total emissions over this period. However, there are no specific reduction targets or climate pledges documented for Pt. Tanabe Indonesia, nor are there any initiatives such as Science Based Targets (SBTi) or other climate commitments reported. The emissions data is not cascaded from a parent company, indicating that these figures are solely from Pt. Tanabe Indonesia's own reporting. The company continues to operate within the context of the pharmaceutical industry, which is increasingly focused on reducing carbon footprints and enhancing sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | |
|---|---|---|
| Scope 1 | 38,435,000 | 00,000,000 |
| Scope 2 | 78,732,000 | 00,000,000 |
| Scope 3 | 34,469,000 | 00,000,000 |
How Carbon Intensive is Pt. Tanabe Indonesia's Industry?
How Carbon Intensive is Pt. Tanabe Indonesia's Location?
Pt. Tanabe Indonesia's Scope 3 Categories Breakdown
Pt. Tanabe Indonesia's Scope 3 emissions, which increased by 19% last year and increased by approximately 19% since 2015, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 28% of total emissions under the GHG Protocol, with "Capital Goods" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Pt. Tanabe Indonesia's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pt. Tanabe Indonesia has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
